- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07571668
Effects of Robotic Hand Therapy on Hand Function and Dexterity in Cerebral Palsy
Effects of Robotic Hand Therapy in Comparison to Conventional Therapy on Hand Function and Dexterity in Children With Hemiplegic Cerebral Palsy; a Randomized Controlled Trial
This randomized controlled trial aims to evaluate the effects of robotic hand therapy using the Syrebo E12 soft-robotic glove compared with conventional physiotherapy on hand function and manual dexterity in children with hemiplegic cerebral palsy. Children aged 7-15 years, classified as GMFCS I-III and MACS I-III, will be recruited from multiple rehabilitation centers in Pakistan. Participants will be randomly allocated (1:1) to either robotic therapy or standard physiotherapy, receiving 45-minute sessions, three times per week for 8 weeks.
The primary outcome is functional hand performance measured by the Jebsen-Taylor Hand Function Test (JTHFT). Secondary outcomes include ABILHAND-Kids, Box and Block Test, Nine-Hole Peg Test, grip strength, and qualitative feedback. Assessments will occur at baseline, week 4, week 8, and at a 6-month follow-up. A mixed-effects repeated-measures ANCOVA will be used for analysis following the intention-to-treat principle.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Qamar Mehmood, Ph.D.
- Telefoonnummer: +923335151063
- E-mail: qamar.mehmood@riphah.edu.pk
Studie Locaties
-
-
-
Islamabad, Pakistan
- Riphah International University
-
Contact:
- Mudassar Ali, Ph.D*
- Telefoonnummer: +923015255090
- E-mail: mudassarpt@gmail.com
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Kind
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Patients diagnosed with Hemiplegic type of Cerebral palsy
- Age 7 to 15 years
- Ability to understand and follow simple instructions
- Gross Motor Function Classification System (GMFCS) levels I-III (ambulatory)
- Manual Ability Classification system (MACS) I to III
- Stable medical condition (no major changes in medication or therapy in the past 3 months).
Exclusion Criteria:
- Patients with severe cognitive dysfunction.
- Fixed contractures or deformities of the upper limb that would prevent safe use of the robotic device.
- Recent upper limb surgery, botulinum toxin injection, or casting within the past 6 months.
- Uncontrolled epilepsy or other unstable medical conditions.
- Visual or auditory impairments that would interfere with assessment or therapy.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Actieve vergelijker: Conventionele fysiotherapie
|
Participants in this group will receive conventional physical therapy based on neurodevelopmental and task-oriented principles, including stretching, strengthening, sensory re-education, and functional hand-use training.
Sessions will last 45 minutes, three times per week for six weeks, delivered by a licensed physical therapist following a standardized treatment checklist.
The program targets improvements in hand strength, dexterity, range of motion, and fine motor skills, with safety and treatment fidelity monitored throughout.
|
|
Experimenteel: Robotic Hand Therapy
|
Participants in this group will receive robotic hand therapy using a glove-based robotic rehabilitation device that provides passive, active-assisted, and resistive training to facilitate repetitive, task-specific hand movements.
Each 45-minute session will be delivered three times per week for six weeks under therapist supervision, focusing on improving grasp-release patterns, finger mobility, and functional hand use.
Therapy intensity will be progressively adjusted based on performance and tolerance, and all sessions will be monitored for safety and adverse events.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Jebsen-Taylor Hand Function Test
Tijdsspanne: 8 Weeks
|
Jebsen-Taylor Hand Function Test (JTHFT) will objectively quantify functional capacity of hand.
|
8 Weeks
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
ABILHAND-Kids
Tijdsspanne: 8 Weeks
|
ABILHAND-Kids for perceived manual ability in daily activities (Subjective assessment).
|
8 Weeks
|
|
Box and Block Test
Tijdsspanne: 8 Weeks
|
Box and Block Test [BBT] for unilateral gross manual dexterity
|
8 Weeks
|
|
Nine-Hole Peg Test (NHPT)
Tijdsspanne: 8 weeks
|
Nine-Hole Peg Test (NHPT) fine finger dexterity (time to place and remove pegs)
|
8 weeks
|
|
o'connor test
Tijdsspanne: 8 Weeks
|
The O'Connor Finger Dexterity Test is a, standardized, timed, aptitude assessment designed to measure fine motor skills and rapid, precise manipulation of small objects.
It is widely used in vocational testing, industrial hiring (assembly line work), and clinical rehab to evaluate finger dexterity by placing three pins into 100 holes.
|
8 Weeks
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Qamar Mehmood, Ph.D., Riphah International University
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- RCRAHS-ISB/REC/PhD/011110
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .